Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10706924 | Current Applied Physics | 2005 | 5 Pages |
Abstract
Leprosy, a debilitating disease shows manifestations ranging from strong cell mediated immune (CMI) response in tuberculoid form (BT/TT) or weak CMI with immunological anergy in lepromatous form (BL/LL). Repeated stimulation with mycobacterial antigen causes activation induced cell death (apoptosis) or anergy in these patients. Previous studies showed in vitro T cell proliferation and increased Th1 response with liposomal (particulate) presentation of mycobacterial antigens with immunomodulators (MDP analog, murabutide and T cell peptide of Trat protein). In the present study, the role of caspases; expression of apoptotic markers, CD95 and CD95L in T cells of leprosy patients and the effect of particulate formulations in the reversal of apoptosis in BT/TT and BL/LL patient group was studied. Caspase 8/3 activity was maximum (p < 0.01) in BL/LL patients in constitutive state, which was followed by decreased activity in BT/TT and normal subjects. Caspase 8/3 activity increased significantly (p < 0.05) from constitutive state after 5 days of antigen stimulation (inducible state). Both the antigens were equally potent in inducing the apoptosis in leprosy patients. A decreased caspase activity using the particulate formulations of both antigens was observed in BL/LL group. The expression of CD95 and CD95L in T cells of leprosy patients increased significantly after 5 days of antigen stimulation. However, % expression of apoptotic markers by T cells of BL/LL patients decreased significantly (p < 0.05) when the particulate formulations were used. To summarize, the particulate formulations of antigens with immunomodulators slowed down the apoptosis and hence T cell anergy in leprosy by stimulating the cells to proliferate.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Condensed Matter Physics
Authors
Vandana Bisht, Vineeta Chattree, Neena Khanna, D.N. Rao,